IDYA
IDEAYA Biosciences, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +7.7% ·
flujo de acciones +6.7% ·
nuevas posiciones netas +7.1%
— fórmula
Acumulación amplia — aumento de acciones entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 100 | +4 | 68.09M | $2.53B | +10 | −5 |
| Q1 2026 | 98 | +2 | 72.39M | $2.41B | +9 | −8 |
| Q4 2025 | 96 | 0 | 74.31M | $2.57B | +1 | — |
| Q3 2025 | 17 | -1 | 45.06M | $1.23B | — | −2 |
| Q2 2025 | 16 | 0 | 43.75M | $919.60M | +1 | −1 |
| Q1 2025 | 13 | -1 | 14.55M | $238.33M | +1 | −2 |
| Q4 2024 | 14 | +1 | 14.99M | $385.22M | +1 | — |
| Q3 2024 | 12 | -1 | 10.73M | $339.97M | — | −1 |
| Q2 2024 | 13 | — | 11.98M | $420.72M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 3.87M | -3.7% | $99.38M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 3.87M | -3.7% | $99.38M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (pasivo) | 3.32M | — | $85.35M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 1.99M | +2.2% | $51.12M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasivo) | 1.99M | +2.2% | $51.12M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 1.84M | +74.5% | $47.21M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Citadel Advisors ✦ | 1.84M | +74.5% | $47.21M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Adage Capital Partners ✦ | 1.20M | +22.4% | $30.84M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 9 | Fisher Asset Management ✦ | 876.60K | +3.3% | $22.53M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Norges Bank ✦ (pasivo) | 520.81K | Nuevo | $13.38M | 0.0% | New | 1 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 423.77K | -15.0% | $10.89M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Marshall Wace ✦ | 312.67K | +23.9% | $8.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Marshall Wace ✦ | 312.67K | +23.9% | $8.04M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 284.27K | +66.9% | $7.31M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 180.68K | -68.2% | $4.64M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | Millennium Management ✦ | 123.01K | -64.0% | $3.16M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Wellington Management ✦ | 39.79K | -5.5% | $1.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Wellington Management ✦ | 39.79K | -5.5% | $1.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Wellington Management ✦ | 39.79K | -5.5% | $1.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Wellington Management ✦ | 39.79K | -5.5% | $1.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 13.76K | -12.6% | $353,709 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 13.76K | -12.6% | $353,709 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 13.76K | -12.6% | $353,709 | 0.0% | ▼ Trim | 3 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Norges Bank | $13.38M | 0.0% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 253 tenedores, 94.40M acciones, $3.10B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.